US$ 29.38
glp 1 for nash Frontiers GLP-1 Receptor Agonists in Non-Alcoholic
Description
Those prices are dependent on Food and Drug Administration approval of the pills

* Correspondence: Nemanja Dimic, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

And the answer depends on severity, timing, and how well other management strategies are working

And as recently as April, industry giant Pfizer halted its development of a GLP-1 competitor following reports of drug-induced liver injury
